Cancer Survivorship Training (CST) is privileged to have partnered with some of the leading minds in cancer survivorship to help create our course content.  Biographies of these individuals are as follows:


Content Contributors


David Cella, PhD
Professor and Chair
Department of Medical Social Sciences
Northwestern University Feinberg School of Medicine


After graduating from Northwestern University with a B.S. in Psychology, Dr. Cella received a doctorate in clinical psychology from Loyola University of Chicago in 1984. From 1981-1984, Dr. Cella completed his pre-doctoral internship and a pre-doctoral fellowship at The New York Hospital-Cornell Medical Center. From 1984-1986, Dr. Cella completed a postdoctoral fellowship in Psycho-Oncology at Memorial Sloan-Kettering Cancer Center, where he conducted research on psychosocial aspects of cancer survivorship and on quality of life evaluation during cancer. In 1987, Dr. Cella became a Clinical Assistant Psychologist at Memorial Sloan-Kettering, at which point he moved to Chicago to direct psychosocial services and research in the cancer program at Rush-Presbyterian-St. Luke’s Medical Center.


From 1987-1997, Dr. Cella built a clinical service and research program with an emphasis on quality of life and outcome evaluation in cancer treatment research. His move to Northwestern University and Evanston Northwestern Healthcare in 1997 brought the expansion of his research in quality of life of chronic illness into a broader study of outcomes in health care. He has developed and is continually refining the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System for outcome evaluation in patients with chronic medical conditions.


Dr. Cella has several grants and contracts to study questions regarding quality of life measurement in clinical trials, cross-cultural equivalence of quality of life measurement, efficacy of psychosocial interventions in oncology, and medical outcomes research. He is principal investigator of the statistical coordinating center for the NIH Roadmap Initiative to build a Patient Reported Outcome Measurement Information System (PROMIS). He is also principal investigator of a contract to develop item banks for the clinical trials supported by the National Institute of Neurological Disorders and Stroke. He has over 300 publications in the area of quality of life measurement in clinical trials and clinical practice.


Vincent Cryns, MD
Professor of Medicine
Chief, Division of En Endocrinology, Diabetes & Metabolism
University of Wisconsin-Madison School of Medicine and Public Health


Dr. Cryns received his bachelor's and medical degrees from Harvard and did subspecialty training in endocrinology at Massachusetts General Hospital. Before coming to Madison, Dr. Cryns was a Professor of Medicine at Northwestern University's Feinberg School of Medicine.


Dr. Cryns leads a multidisciplinary team who focus on understanding how cells die. His group is especially interested in elucidating how abnormalities in cell death contribute to the pathogenesis of cancer and obesity and in translating these insights into improved therapies. Dr. Cryns' research is funded by the NIH, the Breast Cancer Research Foundation, and other agencies. His work has been featured on National Public Radio's "All Things Considered" and highlighted in Nature and Nature Reviews Cancer. Dr. Cryns has been the recipient of several awards, including an Outstanding Junior Faculty Award from the Avon Foundation, and he is an elected member of the American Society for Clinical Investigation.


Wendy Demark-Wahnefried, PhD, RD
Professor and Webb Endowed Chair of Nutrition Sciences
University of Alabama at Birmingham (UAB)
Associate Director for Cancer Prevention and Control
UAB Comprehensive Cancer Center


Dr. Demark-Wahnefried is a nutrition scientist with training in biochemistry, genetics, and behavioral science.  For the past two decades, her research career has spanned basic science studies focused on determining mechanisms of action of food-related components on neoplastic progression, to clinical research that involves nutrition-related concerns of cancer patients, as well as determining effective lifestyle interventions that improve the overall health of cancer survivors and populations at high risk for cancer (relatives of cancer survivors, rural African-Americans residing in high incidence counties, etc).  Her laboratory has conducted some of the largest studies exploring metabolic and body composition changes, as well as energy balance, in response to cancer treatment.  An area of research in which Dr. Demark-Wahnefried has experienced particular success, is in the delivery of home-based lifestyle interventions among cancer survivors where she has led and continues to lead a number of  NIH-funded trials aimed at improving the diet and exercise behavior of cancer survivors. This work has given rise to over 150 publications, and recognition as a Komen Professor of Survivorship. 


In addition to her research, Dr. Demark-Wahnefried also serves on several committees, including the American Cancer Society’s Guidelines Panel for Nutrition and Physical Activity among Cancer Survivors, the World Cancer Research Fund, the American College of Sports Medicine Guidelines Panel for Physical Activity in Cancer Survivors, the American Society of Clinical Oncology Committee on Cancer Survivorship, and the National Cancer Policy Forum of the Institute of Medicine (IOM).  In October 2011, she chaired the IOM workshop on “The Role of Obesity on Cancer Recurrence and Survival.”  She also is the current President-Elect for the American Society of Preventive Oncology. 


Carol J. Fabian, MD
Distinguished Professor of Medicine, Division of Clinical Oncology
Morris Family Endowed Chair in Cancer Prevention
Medical Director Breast Cancer Prevention and Survivorship Centers


Dr. Fabian is an internationally and nationally recognized leader in risk assessment and prevention trials for breast cancer. She is a board certified medical oncologist, has 30 years of experience in conducting breast cancer research, and has had continuous funding from the National Cancer Institute for performance of clinical research trials for more than 20 years. She leads the Cancer Prevention and Survivorship Research Program and is the Principle Investigator for a number of ongoing prevention trials in breast cancer funded by the National Cancer Institute, including letrozole for postmenopausal women taking hormone replacement therapy, a diet and exercise trial for postmenopausal overweight women, and a flaxseed derivative trial for pre-menopausal women.


Dr. Fabian received her bachelor’s and medical degrees from the University of Kansas and joined the faculty as an assistant professor at the University of Kansas Medical Center after completing an oncology fellowship in 1977. She was appointed Professor in 1987. She previously served as the Medical Director of the Clinical Outpatient Cancer Center and currently serves as the Director of the Breast Cancer Prevention Center and the Breast Cancer Survivorship Center, both of which she founded. Dr. Fabian was awarded the Kansas Masonic Endowed Research Chair in 2004 and has received numerous lay and academic awards for her achievements. She has served on numerous scientific advisory boards for the National Cancer Institute and the Susan G. Komen Foundation, and on ASCO and AACR scientific program committees. She currently serves as a reviewer and editorial board member for numerous scientific publications, including The Journal of the National Cancer Institute, Cancer Epidemiology Biomarkers and Prevention, and Journal of Clinical Oncology. Dr. Fabian teaches the module on Breast Cancer Risk Assessment and Prevention annually at the School of Breast Oncology and authored the module on breast cancer risk assessment and prevention for the American Society of Clinical Oncology, released in 2007 as a prevention teaching tool.


Linda Frazier, MD, MPH
Professor and Director of Research Obstetrics and Gynecology
University of Kansas School of Medicine-Wichita


Dr. Frazier is board certified in occupational and environmental medicine and in internal medicine. She has been on the faculty at Duke University for ten years and is currently Associate Professor at the University of Kansas School of Medicine. Dr. Frazier directed the educational outreach program, EPOCH-Envi (Educating Physicians in Occupational Health and the Environment), designed to teach OEM concepts to primary care physicians.   Dr. Frazier has been awarded NIH funding to evaluate employment issues of cancer survivors and has published work in the field of employment and cancer, the state of cancer survivorship, and the educational needs of oncology nurses in delivery of survivorship care.


Heather Hampel, MS, CGC
Associate Director, Division of Human Genetics
Professor, Internal Medicine
Genetic Counselor
The Ohio State University Comprehensive Cancer Center –
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute


Ms. Hampel completed her Bachelor of Science degree in Molecular Genetics at the Ohio State University in 1993.  She attained her Master’s degree in Human Genetics from Sarah Lawrence College in 1995.  Dr. Hampel received certification from the American Board of Genetic Counseling in 1996.  She worked as a cancer genetic counselor at Memorial Sloan-Kettering Cancer Center in Manhattan before moving to The Ohio State University in 1997.  Ms. Hampel is a Professor in the Department of Internal Medicine and Associate Director of the Division of Human Genetics.  She is the study coordinator for the Columbus-area HNPCC study which enrolled over 1,500 colon cancer patients and over 500 endometrial cancer patients to determine the frequency of HNPCC among newly diagnosed patients with these cancers.  This study culminated in first author publications in the New England Journal of Medicine in May of 2005, Cancer Research in August of 2006, and the Journal of Clinical Oncology in December of 2008.  Heather was the President of the American Board of Genetic Counseling for 2009 and 2010.


Heather Greenlee, ND, PhD
Assistant Professor Epidemiology
Assistant Professor of Medical Oncology
College of Physicians and Surgeons
Columbia University, New York, NY


Dr. Greenlee is a naturopathic physician and an epidemiologist. Her research focuses on the use of complementary and alternative medicine (CAM) and lifestyle modifications for breast cancer prevention and control. Dr. Greenlee uses observational studies and clinical trials to study what women can do, beyond conventional treatment, to prevent breast cancer, decrease side effects of treatment, and improve prognosis. She studies how diet, physical activity, and weight loss after a breast cancer diagnosis may affect breast cancer outcomes, with a particular emphasis on minority breast cancer survivors. Through funding from the National Cancer Institute (NCI), Dr. Greenlee is developing strategies for increasing fruit and vegetable intake and reducing fat intake among Latina breast cancer survivors. Dr. Greenlee also studies the effects of antioxidant supplement use during breast cancer treatment. As part of a K23 Mentored Patient-Oriented Career Development award from the NCI, she will study the effects of Coenzyme Q10 in preventing doxorubicin-induced cardiotoxicity. Dr. Greenlee completed a postdoctoral fellowship in cancer prevention at the Fred Hutchinson Cancer Research Center, funded by the National Center for Complementary and Alternative Medicine (NCCAM), and a postdoctoral fellowship in cancer prevention and control at Columbia University, funded by the NCI. She has served on NCCAM grant review committees and serves on the executive committee of the Society for Integrative Oncology.


Michael Krychman, MD
Gynecologist, specialist in sexual health, expert in survivorship medicine
Executive Director: The Southern California Center for Sexual Health and Survivorship, Newport Beach, CA
Medical Director: Sexual Medicine at Hoag Hospital, Newport Beach, CA
Clinical faculty member at the University of Southern California, Los Angeles, CA


As a doctor of sexual medicine, a board certified obstetrician and gynecologist, and a clinical sexual counselor and author, Dr Krychman has devoted his career to helping patients and their partners overcome sexual health challenges and experience a higher quality of physical intimacy. Dr. Krychman is also a specialist in survivorship medicine and provides life coaching and care plans to optimize the health and wellness of patients with chronic diseases or cancer.


Dr. Krychman is the executive director of the Southern California Center for Sexual Health and Survivorship Medicine and the medical director of sexual medicine at Hoag Hospital in Newport Beach, California. He formerly served as co-director of the Sexual Medicine and Rehabilitation Program at Memorial Sloan-Kettering Cancer Center and as an associate professor at Weill Cornell Medical School, both in New York City.


Dr. Krychman is a renowned researcher, author, and lecturer in the field of sexual medicine and is known both nationally and internationally for his research and work in the field of female sexual health and cancer survivorship. His clinical interests are diverse, ranging from chemotherapy-induced chemical dyspareunia to management of sexual dysfunction in cancer and non-cancer patients. His special interests include sexual pain disorders, loss of libido, and chronic medical illness and its impact on female sexual function, as well as breast cancer sexuality.


He has published numerous articles in peer-reviewed journals, served as a reviewer and editorial advisor for many publications, and authored several textbook chapters and books, including 100 Questions and Answers About Women's Sexual Wellness and Vitality: A Practical Guide for the Woman Seeking Sexual Fulfillment. He has been featured in The New York Times, U.S. News & World Report, The Wall Street Journal, Health magazine, and many other publications. He is also the scientific chair for the International Society for the Study of Women’s Sexual Health (ISSWSH) annual conference for 2010 in St. Petersburg, Florida.


Fluent in French and English, Dr. Krychman obtained his doctorate in medicine and masters in surgery from McGill University Faculty of Medicine in Montreal, Canada, where he was named a “Great Distinction Medical Scholar” and completed his residency in the Department of Obstetrics and Gynecology at Cedars-Sinai Medical Center in Los Angeles, California.


Daniel J. Lenihan, MD
Professor of Medicine, Division of Cardiovascular Medicine
Director, Clinical Research Program
Vanderbilt Heart


Dr. Lenihan joined Vanderbilt in 2009 from the University of Texas M.D. Anderson Cancer Center.  For over 20 years, Dr. Lenihan has focused his clinical research in heart failure with a concentrated interest is cardio-oncology.  As the Director of Clinical Research in the Division of Cardiovascular Medicine, Dr. Lenihan also manages over 100 clinical trails and continues to enhance and foster collaboration among a host of colleagues both internally and throughout the world.  He has numerous publications and honors in the field of cardiology and cardio-oncology. Dr. Lenihan has helped pioneer the field of Cardio-oncology and is currently the President of the International Cardio-oncology Society.  Dr. Lenihan completed his medical degree at the University of Tennessee School of Medicine and his post-graduate training at  Wright-Patterson Air Force Base and the University of Cincinnati.


The Oncofertility Consortium ( brings diverse experts together to solve the previously intractable problem of fertility loss after cancer treatment. The Consortium is an interdisciplinary team of researchers and clinicians created with the goal to explore and expand the future of young cancer survivors whose disease or treatment may impair their reproductive ability, and to advance research and improve clinical care. The Consortium, at the intersection of oncology and reproductive medicine, expands fertility options for pediatric and adolescent/young adult cancer survivors through collaboration with scientists, clinicians, social scientists, and humanists who are dedicated to developing new fertility preservation options and reducing cancer patients’ barriers to care.


Kathryn Schmitz, PhD, MPH
Associate Professor of Epidemiology
University of Pennsylvania Perelman SOM
Senior Scholor, Epidemiology

BA (Economics), University of North Carolina, 1984.
MS Ed. (Exercise Physiology), Queens College, City University of New York, 1994.
Ph.D. (Kinesiology, Minor: Epidemiology ), University of Minnesota, 1998.
MPH (Epidemiology), University of Minnesota, 1999.


Dr. Schmitz focuses her research on the role of physical activity on the etiology, prevention, treatment, and rehabilitation from chronic diseases, with primary focus on obesity and cancer.  In her SHE (Strong, Healthy, and Empowered) trial, Dr. Schmitz observed that twice weekly strength training was adequate to prevent age associated increases in % body fat and to attenuate age associated increases in intra-abdominal (visceral) fat among overweight and obese midlife women. These findings are of public health relevance in determining the dose of exercise needed to avoid age associated increases in obesity.


Her recently completed PAL (Physical Activity and Lymphedema) Trial recruited breast cancer survivors 1-15 years out from diagnosis for a 2 group parallel design randomized controlled trial to assess the safety of twice weekly strength training for women with or at risk for lymphedema.   The study demonstrated that slowly progressive supervised strength training in community settings is safe for survivors with and at risk for lymphedema.  The strength and body image improvements from the intervention were substantive.  The results of this trial were highly influential for changes in clinical practice and national guidelines to breast cancer survivors regarding the safety of weight lifting. 


Her ongoing WISER Sister Trial is recruiting premenopausal women at elevated risk for breast cancer into a dose response aerobic exercise intervention trial.  For more information on WISER Sister, see:


Dr. Schmitz is the principal investigator of the Penn TREC Survivor Center, one of 4 NCI funded Transdiscipinary Research on Energetics and Cancer, which will provide 5 years of funding toward the mission of research, education, and outreach on the role of exercise and weight control for improving the length and quality of cancer survivorship, starting early in 2011.


Dr. Schmitz has won multiple awards from the American Heart Association, including the Jeremiah Stamler Award for New Investigators, the Trudy Bush Fellowship for Cardiovascular Research in Women's Health, and the Majorie Bowman New Investigator Award of Excellence.


Lillie Shockney, RN., BS., MAS
University Distinguished Service Associate Professor of Breast Cancer
Depts of Surgery and Oncology
Administrative Director, Johns Hopkins Breast Clinical Programs
Administrative Director, Johns Hopkins Cancer Survivorship Programs
Associate Professor, JHU School of Medicine,  Depts of Surgery, Oncology & Gynecology and Obstetrics
Associate Professor, JHU School of Nursing


A two-time breast cancer survivor, Dr. Shockney has worked tirelessly to improve the care of breast cancer patients around the world. She is a registered nurse with a Bachelor of Science degree in health care administration from Saint Joseph's College and a Masters in Administrative Science from the Johns Hopkins University. Dr. Shockney has worked at Johns Hopkins since 1983. She is responsible for the quality of care programs; patient education programs; the survivor volunteer team; community outreach at a local, regional and national level; the Web site and patient advocacy. Dr. Shockney is also certified as a breast care oncology nurse and a breast cancer patient navigator.


Dr. Shockney is a published author and nationally recognized public speaker on the subject of breast cancer. She has written 13 books and more then 200 articles on this subject. She serves on the medical advisory board of several national breast cancer organizations and is the co-founder and vice president of a national non-profit organization called Mothers Supporting Daughters with Breast Cancer.


Dr. Shockney is also editor-in-cheif of a new peer-reviewed medicine journal called Journal of Oncology Navigation and Survivorship, which launched in Spring 2011.  She also serves on the Leadership Council of the Academy of Oncology Nurse Navigators, a national organization that provides a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients.


Dr. Shockney is the consultant for breast cancer for national ABC News and Good Morning America, and is also consulted regularly by the Today Show and CNN. She is an active lecturer on various topics related to breast cancer and spoke at the 2010 World Economic Forum, which featured her lecture, “The Cancer Paradigm Shift: Who Will Take Care of the Breast Cancer Survivors?”.


Dr. Shockney serves as “Ask an Expert” for several breast cancer Web sites, including and the Johns Hopkins Avon Foundation Breast Center, among many others. She chairs the National Consortium of Breast Centers Quality Initiatives Task Force. She also is an active clinical researcher with a focus on quality of life issues for survivors, as well as a strong advocate of the value of humor as a beneficial form of complementary medicine.  View Dr. Shockney's online seminar, Breast Cancer Detection and Treatment: What All Women Should Know.


In 2008, the Johns Hopkins Board of Trustees appointed Dr. Shockney to a chair as a University Distinguished Service Assistant Professor of Breast Cancer. This is the first time in the history of the institution that a hospital nurse has been appointed to a distinguished service designation.


Shelby Terstriep, MD
Medical Director, embrace Survivorship Program


Dr. Terstriep practices hematology and oncology in Fargo, North Dakota.  She is the Medical Director for embrace, Sanford's Cancer Survivorship Program and has a special interest in cancer survivorship.   Sanford Cancer’s embrace Survivorship Program brings together cancer patients, family members and caregivers to help address the emotional, physical and financial effects of cancer on patients and their families.  Embrace will provide access to survivorship care across the Sanford network and serves as a leader in the delivery of community based survivorship care.  Dr. Terstriep completed her residency and fellowship training at the Mayo Graduate School College of Medicine, Rochester, MN. 


Amye Tevaarwerk, MD
Faculty, University of Wisconsin School of Medicine and Public Health


Dr. Tevaarwerk obtained her medical degree from Washington University School of Medicine and completed an internship and residency in internal medicine at Barnes Jewish Hospital. Prior to entering clinical fellowship, she worked as a hospitalist for a year at Barnes Jewish Hospital in St. Louis. She completed a medical oncology fellowship at the University of Wisconsin. Her academic area of interest is breast oncology, with a focus on new drug development and women’s health issues as they relate to cancer survivorship. Dr. Tevaarwerk is a member of the UW Health Breast Center and part of Breast Disease-Oriented Working Group, through which multiple clinical trials in breast cancer are helping to find better treatments for those with cancer.


Janette Vardy, MD, FRACP, PhD
Senior Lecturer
Faculty of Medicine
University of Sydney, Sydney, Australia


Dr. Vardy is a staff medical oncologist working as a clinician researcher at the Sydney Cancer Centre, and is a senior lecturer at the University of Sydney, Australia. She graduated medicine with honors from the University of Newcastle, Australia. She received the Margaret Dunn Resident of the Year award in 1999 and completed internal medicine and specialty training in Medical Oncology, obtaining a Fellowship from the Royal Australasian College of Physicians in 2002. From 2003-2006 she completed a Clinical Research Fellowship at the Princess Margaret Hospital in Toronto and a PhD in Clinical Epidemiology at the University of Toronto under the supervision of Dr Ian Tannock.


Upon returning to Australia in 2007 Dr. Vardy received a Cancer Institute New South Wales fellowship which has enabled her to establish a research program in cancer survivorship at the Sydney Cancer Centre. Her primary area of research is in cognitive function and fatigue in cancer survivors. For this work she has received two Young Investigator Awards (ASCO, MASCC), a PhD scholarship and an ASCO Career Development Award.


Recently Dr. Vardy has commenced work on establishing trials investigating the benefits of exercise in cancer patients. She is co-chair of the International Cognition and Cancer Task Force, and chair of the Scientific Advisory Committee for the Psycho-Oncology Co-operative Group, Australia.


Course Editors:
The following individuals are helping Dr. Klemp edit CST's courses:


Joanne Lester, PhD, CRNP, ANP-BC, AOCN
Research Scientist / Oncology Nurse Practitioner
Comprehensive Cancer Center -
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
Clinical Assistant Professor, College of Nursing


Cancer survivorship across the continuum, specifically issues experienced by breast cancer survivors.  In addition, women at increased risk of breast cancer development, tissue markers relevant to risk status, and adherence to chemoprevention.


Dr. Lester is currently exploring professional barriers related to personalized cancer survivorship care in Ohio, specifically in counties with minimal or no access to cancer care, including Appalachia.  The development of a mentored professional nursing education model may enhance survivorship care across the continuum.  These research efforts are funded by Susan G. Komen For the Cure, Columbus Afffiliate. Dr. Lester has developed the Urogenital Atrophy Questionnire, a self-report instrument that characterizes symptoms related to urogenital atrophy. A pilot study is in progress to identify reliable objective markers of atrophic vaginitis in breast cancer survivors. Combined, these measures will provide a brief and concise instrument for use in the oncology clinical setting that measures the signs and symptoms of urogenital atrophy. Pending is a pilot study to measure the anti-inflammatory effects of omega 3 fatty acids on atrophic vaginitis in breast cancer survivors. These research efforts are funded by the Oncology Nursing Society and the Rehabilitation Nurses' Foundation.


Mary McCabe, RN
Director, Cancer Survivorship Initiative
Memorial Sloan-Kettering


Mary McCabe is Director of the Cancer Survivorship Program at the Memorial Sloan-Kettering Cancer Center, where she is responsible for developing and implementing center wide comprehensive programs for adult cancer survivors. She is also a faculty member in the Division of Medical Ethics at the Cornell Weill Medical College. A graduate of Trinity College, Emory University, and Catholic University, Mary McCabe held several positions at the National Cancer Institute before joining the Memorial Sloan-Kettering Cancer Center, including Assistant Director of the Division of Cancer Treatment and Diagnosis, Director of the Office of Clinical Research Promotion, and faculty member of the Department of Bioethics at the National Institutes of Health (NIH). Mary McCabe has served as a member of numerous committees, including Co-Chair of the Clinical Research Networks Working Group at the National Institute of Health, Chair of the Clinical Trials Integration Committee at the National Cancer Institute (NCI), the Scientific Advisory Board, the Lance Armstrong Foundation, and is a faculty member of the NCI Adolescent and Young Adult Oncology Progress Review Group. She is a member of the Oncology Nursing Society, American Society of Clinical Oncology, American Nurses Association, Women in Cancer Research, and American Society for Bioethics and Humanities. Mary McCabe has published numerous peer-reviewed articles, serves on the editorial boards for Seminars in Oncology Nursing, Oncology, and Oncology News International, and is editor of Oncology for Nurses. She has received numerous awards, including the American Cancer Society Merit Award, Oncology Nursing Society Leadership Award, NIH Outstanding Performance Award, NIH Director’s Award, and the Outstanding Alumnae Award, Emory University.

For Healthcare Professionals

Cancer Survivorship Training (CST) provides continuing education and training tools to help healthcare professionals meet their professional needs and improve the lives of cancer patients.


Learn More

Company Overview

Download the Cancer Survivorship Training company brochure.




- AJMC highlights CST as a valued resource
- Genetic Testing vs. Family History
- The WHO Says Cancer Cases Will Soar
- AONN+ Announces New Leadership Council Member Jennifer Klemp